Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
The changing and dynamic epidemiology of meningococcal disease
Vaccine, Volume 30, No. SUPPL. 2, Year 2012
Notification
URL copied to clipboard!
Description
The epidemiology of invasive meningococcal disease continues to change rapidly, even in the three years since the first Meningococcal Exchange Meeting in 2008. Control of disease caused by serogroup C has been achieved in countries that have implemented meningococcal C or quadrivalent meningococcal ACWY conjugate vaccines. Initiation of mass immunization programs with meningococcal A conjugate vaccines across the meningitis belt of Africa may lead to the interruption of cyclical meningococcal epidemics. A meningococcal B vaccination program in New Zealand has led to a decreased incidence of high rates of endemic serogroup B disease. Increases in serogroup Y disease have been observed in certain Nordic countries which, if they persist, may require consideration of use of a multiple serogroup vaccine. The imminent availability of recombinant broadly protective serogroup B vaccines may provide the tools for further control of invasive meningococcal disease in areas where serogroup B disease predominates. Continued surveillance of meningococcal disease is essential; ongoing global efforts to improve the completeness of reporting are required. © 2011 Elsevier Ltd.
Authors & Co-Authors
Halperin, Scott A.
Canada, Halifax
Iwk Health Centre
Bettinger, Julie A.
Canada, Vancouver
Bc Children's Hospital
Greenwood, Brian M.
United Kingdom, London
London School of Hygiene & Tropical Medicine
Harrison, Lee H.
United States, Pittsburgh
University of Pittsburgh
Ladhani, Shamez N.
United Kingdom, London
Public Health England
Mcintyre, Peter B.
Australia, Parramatta
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Australia
Ramsay, Mary E.
United Kingdom, London
Public Health England
Palazzi Sáfadi, Marco Aurélio
Brazil, Sao Paulo
Universidade de São Paulo
Statistics
Citations: 259
Authors: 8
Affiliations: 7
Identifiers
Doi:
10.1016/j.vaccine.2011.12.032
ISSN:
18732518
Research Areas
Maternal And Child Health
Study Design
Cohort Study